Nona Biosciences Announces Licensing Agreement with the University of Alabama at Birmingham to Support B Cell Development Research
Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to I™), today announced a ...
Diffuse Large B-Cell Lymphoma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
Diffuse Large B-Cell Lymphoma Companies are involved in targeted therapeutics development with respective active and inactive ...
Oncology Nurse Advisor3d
Ibrutinib, Acalabrutinib Have Distinct Metabolic Effects on CLL Cells
Cells treated with ibrutinib and acalabrutinib each had a unique set of 13 m/z signals, which opens up the possibility of studying these metabolites as biomarkers of therapeutic response.
CAR-TCR Summit Coverage – Track Latest Insights on Novel CAR-T Cell Therapies for B-Cell Malignancies | DelveInsight
A case study on how DelveInsight supported a client with a focused CAR-TCR Summit coverage plan to gain exclusive insights into CAR-T therapies for B-cell malignancies.New York, USA, Feb. 21, 2025 (GL ...
Chinese researchers find bat virus enters human cells via same pathway as COVID
(Reuters) - A newly discovered bat coronavirus uses the same cell-surface protein to gain entry into human cells as the ...
PMLiVE8d
Pfizer granted FDA approval for Adcetris combination in large B-cell lymphoma
Pfizer’s Takeda-partnered blood cancer drug Adcetris (brentuximab vedotin) has been approved by the US Food and Drug ...